Please login to the form below

Not currently logged in

Diane DiGangi Trench appointed as country head of Sandoz UK

Previously, DiGangi Trench held the position of vice-president, market access and patient services at Sandoz in the US

Sandoz, the generics division of Novartis, has announced the appointment of Diane DiGangi Trench as its new UK country head.

Prior to becoming UK country head, DiGangi Trench (pictured right) held the position of vice-president, market access and patient services at Sandoz in the US.

In her new role, she will work to continue to expand access to biosimilar, generic and originator drugs for patients in the UK.

DiGangi Trench will be based in Sandoz’s headquarters in Camberley, and she will report to Christophe Delenta, the head of cluster I, Sandoz Region Europe.

“I am delighted to join the UK organisation as Country Head as we celebrate our 15 years in biosimilar medicines,” commented DiGangi Trench.

“Sandoz is a purpose-driven organisation and we are proud to support the NHS with our generic, biosimilar and originator medicines,” she added.

The appointment of DiGangi Trench also coincides with the 15th anniversary of the launch of Sandoz’s first biosimilar medicine approved for use in the UK, the company said in a statement.

12th May 2021

From: PME


COVID-19 Updates and Daily News

Featured jobs


Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....